DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Semaxanib
Semaxanib
Supplemental Table
Characterization of the Small Molecule Kinase Inhibitor SU11248 (Sunitinib/ SUTENT in Vitro and in Vivo
Using Next-Generation Sequencing to Find Targetable Genomic Lesions in a Case of Relapsed Extramedullary Acute Myeloid Leukemia
Hypertension Secondary to Anti-Angiogenic Therapy: Experience with Bevacizumab
Systematic Analysis of Gene Expression Profiles Reveals
Snapshot: Breast Cancer Kornelia Polyak and Otto Metzger Filho Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215 USA
Downloaded from Bioscientifica.Com at 09/26/2021 09:35:42AM Via Free Access
Stembook 2018.Pdf
Synthetic and Biological Investigations Into Hypoxia-Activated Anti-Tumour Codrugs
(12) Patent Application Publication (10) Pub. No.: US 2013/0230511 A1 HEYMACH Et Al
WO 2015/187677 Al 10 December 2015 (10.12.2015) P O P C T
The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward
Receptor Tyrosine Kinase Regulation with Anti-Tumorigenensis/ Angiogenesis Properties
VEGF • Epidermal Growth Factor – EGF – Receptors (Cell Membrane) E.G
Antiangiogenic Therapy and Surgical Practice
Phase II Study of the Antiangiogenic Agent SU5416 in Patients with Advanced Soft Tissue Sarcomas
Smart Drugs:Tyrosine Kinase Inhibitors in Cancer Therapy
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
Top View
The Molecular Crosstalk Between the MET Receptor Tyrosine Kinase and the DNA Damage Response—Biological and Clinical Aspects
(12) United States Patent (10) Patent No.: US 9,345,766 B2 Zhang Et Al
Snapshot: Breast Cancer Kornelia Polyak and Otto Metzger Filho Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215 USA
Drug Resistance in Mutant FLT3-Positive AML
Riport Letöltése
Synthesis and Preliminary Evaluation of 5,7-Dimethyl-2-Aryl-3H-Pyrrolizin
Synthesis and Evaluation of Novel 2-Pyrrolidone-Fused (2-Oxoindolin-3-Ylidene)Methylpyrrole Derivatives As Potential Multi-Target Tyrosine Kinase Receptor Inhibitors
Synthesis and Biophysical Insights Into the Binding of a Potent Anti
Hypoxia-Dependent Drivers of Melanoma Progression Simona D’Aguanno1†, Fabiana Mallone2†, Marco Marenco2, Donatella Del Bufalo1*† and Antonietta Moramarco2†
THERAPY CODES 4-Factor Concentrate F014 5A2A F017
Synthesis and Preliminary Evaluation of 5,7-Dimethyl-2-Aryl-3H- Pyrrolizin-3-Ones As Angiogenesis Inhibitors
Selleckchem Kinase Inhibitor Library 96Well Format
Personalizing Medicine in Head and Neck Squamous Cell Carcinoma: the Rationale for Combination Therapies
RTK Inhibitors in Melanoma: from Bench to Bedside
Src Kinase Inhibitors for the Treatment of Sarcomas: Cellular and Molecular Mechanisms of Action Audrey Cathryn Shor University of South Florida
Early Clinical Development of Targeted Anticancer Agents
Duke University Dissertation Template
Radioiodinated Sunitinib As a Potential Radiotracer for Imaging
Oncompass Report NÉV Anonymous a Realtime Oncology Molecular Treatment Calculator Számításaival
Pyrrole Indolin-2-One Based Kinase Inhibitor As Anti-Cancer Agents
Strategies for Molecular Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase in Cancer
Wo 2010/081443 A2
Comparative Effect of Tyrosine Kinase Inhibitors in Human Cancer Cell Lines
Comprehensive Review of Targeted Therapy for Colorectal Cancer
Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
Overcoming Acquired Resistance to BRAF Inhibitors by Novel